×

Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury

  • US 20050208092A1
  • Filed: 03/22/2004
  • Published: 09/22/2005
  • Est. Priority Date: 03/22/2004
  • Status: Active Grant
First Claim
Patent Images

1. A medical device comprising:

  • an implantable structure;

    a basecoat matrix, including a combination of rapamycin and a cytostatic glucoside, in therapeutic dosages, incorporated in a first polymeric material, the basecoat matrix being affixed to the surface of the implantable medical device; and

    a topcoat, including a second polymeric material, affixed to the basecoat matrix for controlling the elution rate of the rapamycin and the cytostatic glucoside.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×